Safety and immunogenicity of a combined DTacP-sIPV-Hib vaccine in animal models

The DTacP-sIPV-Hib combination vaccine can replace the single-component acellular pertussis, diphtheria, tetanus, polio, and Haemophilus influenzae type B vaccines. In this study, we evaluated the safety and immunogenicity of a newly developed DTacP-sIPV-Hib combination vaccine in animal models. We...

Full description

Bibliographic Details
Published in:	Human Vaccines & Immunotherapeutics
Main Authors:	Yuntao Zhang, Yancen Guo, Yuan Dong, Yingwei Liu, Yuxiu Zhao, Shouzhi Yu, Shihui Li, Chongyang Wu, Baifeng Yang, Wanli Li, Xiaoli Wei, Yadan Zhang, Yunchao Huang, Hui Wang, Xiaoming Yang
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2022-12-01
Subjects:	safety immunogenicity dtacp-sipv-hib vaccine animal model
Online Access:	http://dx.doi.org/10.1080/21645515.2022.2160158

Similar Items

Preclinical Immunogenicity Evaluation of a DTacP-sIPV/Hib Combination Vaccine in Rodent Models Under Varying Formulations and Immunization Schedules
by: Yixian Fu, et al.
Published: (2025-09-01)

Immunogenicity of a Candidate DTacP-sIPV Combined Vaccine and Its Protection Efficacy against Pertussis in a Rhesus Macaque Model
by: Xiaoyu Wang, et al.
Published: (2021-12-01)

Concomitant administration of diphtheria, tetanus, acellular pertussis and inactivated poliovirus vaccine derived from Sabin strains (DTaP-sIPV) with pentavalent rotavirus vaccine in Japanese infants
by: Yoshiyuki Tanaka, et al.
Published: (2017-06-01)

Post-Marketing Safety Surveillance of a Childhood Pentavalent Diphtheria–Tetanus–Acellular Pertussis–Polio and Haemophilus influenzae Type B (DTaP-IPV//Hib) Vaccine in South Korea
by: Kuhyun Yang, et al.
Published: (2022-12-01)

The Implementation of Pentavalent Vaccine DTaP/IPV/Hib within National Immunization Schedule
by: Irina V. Mikheeva, et al.
Published: (2019-09-01)

The progress of postapproval clinical studies on Sabin IPV
by: Li Shi, et al.
Published: (2022-01-01)

Lagging Immune Response to <i>Haemophilus influenzae</i> Serotype b (Hib) Conjugate Vaccine after the Primary Vaccination with Hib of Infants in The Netherlands
by: Leo Schouls, et al.
Published: (2020-06-01)

DTaP5-IPV-Hib-HepB, a hexavalent vaccine for infants and toddlers
by: Andrew W. Lee, et al.
Published: (2017-02-01)

Safety and immunogenicity of a fully-liquid DTaP-IPV-Hib-HepB vaccine (Vaxelis™) in premature infants
by: Marissa B. Wilck, et al.
Published: (2021-01-01)

Immunogenicity and safety of 3-dose primary vaccination with combined DTPa-HBV-IPV/Hib in Indian infants
by: Sanjay K. Lalwani, et al.
Published: (2017-01-01)

Estrategia regulatoria del desarrollo de Quimi-Hib®, vacuna conjugada semisintética contra el Haemophilus influenzae tipo b
by: Arlene Rodriguez Silva, et al.
Published: (2023-03-01)

A Phase I study to evaluate safety and tolerability of DTaP-IPV + Hib vaccine in healthy adult volunteers in India
by: Hitt Sharma, et al.
Published: (2023-08-01)

Changes in vaccination practices among infants after the introduction of DTaP-IPV/Hib combination vaccines
by: Hee-Jin Kim, et al.
Published: (2024-06-01)

Adverse events following immunization of co- and separate administration of DTaP-IPV/Hib vaccines: A real-world comparative study
by: Yiqing Zhu, et al.
Published: (2024-12-01)

Occurrence of Haemophilus influenzae type b (Hib) meningitis in a 2 month-old infant in the Hib vaccination era
by: Yoshiaki Cho, et al.
Published: (2022-06-01)

RNA gene profile variation in peripheral blood mononuclear cells from rhesus macaques immunized with Hib conjugate vaccine, Hib capsular polysaccharide and TT carrier protein
by: Jing Tang, et al.
Published: (2018-01-01)

Control of vaccine preventable diseases in Australian infants: reviewing a decade of experience with DTPa-HBV-IPV/Hib vaccine
by: Julianne Bayliss, et al.
Published: (2021-01-01)

Immunization Status Relationships: DPT-HB-HIB with Pneumonia in Age 12-24 Months at Babakan Sari Community Health Center Bandung
by: Benedika Mardewi Iswari
Published: (2017-07-01)

Immunization Status Relationships: DPT-HB-HIB with Pneumonia in Age 12-24 Months at Babakan Sari Community Health Center Bandung
by: Benedika Mardewi Iswari
Published: (2017-07-01)

Pattern of functional antibody activity against Haemophilus influenzae type b (Hib) in infants immunized with diphtheria-tetanus-pertussis/Hib Brazilian combination vaccine
by: D.C.S. Matos, et al.
Published: (2009-12-01)

Prevalence of Risk Factors for Diphtheria: CLTS and DPT-HB-HIB3 Immunization Coverage in East Java (Periode 2018-2020)
by: Niken Istania Nuryanti, et al.
Published: (2022-07-01)

RESULTS OF A MULTICENTER CLINICAL STUDY OF A NEW COMBINATION VACCINE DTaP-HepB+Hib PRODUCTION OF THE CPA «MICROGEN» FOR IMMUNIZATION OF CHILDREN 6 MONTHS
by: I. V. Feldblyum, et al.
Published: (2018-04-01)

Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course in healthy Korean infants: phase III, randomized study
by: Ki Hwan Kim, et al.
Published: (2019-02-01)

Long-term antibody persistence against hepatitis B in adolescents 14–15-years of age vaccinated with 4 doses of hexavalent DTPa-HBV-IPV/Hib vaccine in infancy
by: Tino F. Schwarz, et al.
Published: (2019-01-01)

Safety, immunogenicity and persistence of immune response to the combined diphtheria, tetanus, acellular pertussis, poliovirus and Haemophilus influenzae type b conjugate vaccine (DTPa-IPV/Hib) administered in Chinese infants
by: Yanping Li, et al.
Published: (2017-03-01)

Evaluation of Haemophilus influenzaetype b carrier status among children 10 years after the introduction of Hib vaccine in Brazil
by: Rosemeire Cobo Zanella, et al.
Published: (2015-09-01)

A randomized, open-label clinical trial to evaluate immunogenicity and safety of an indigenously developed DTwP-Hib tetravalent combination vaccine (Easyfour®-TT) with Quadrovax® in Indian infants
by: Lalitendu Mohanty, et al.
Published: (2017-09-01)

FAMILIAL CASE OF PURULENT HAEMOPHILUS INFLUENZAE MENINGITIS
by: T. V. Egorova, et al.
Published: (2017-09-01)

Immunogenicity and safety of primary and booster vaccination with 2 investigational formulations of diphtheria, tetanus and Haemophilus influenzae type b antigens in a hexavalent DTPa-HBV-IPV/Hib combination vaccine in comparison with the licensed Infanrix hexa
by: Timo Vesikari, et al.
Published: (2017-07-01)

Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course and a booster dose in healthy children in Russia: a phase III, non-randomized, open-label study
by: Victor Romanenko, et al.
Published: (2020-09-01)

DTwP-HB-Hib: antibody persistence after a primary series, immune response and safety after a booster dose in children 18–24 months old
by: Hartono Gunardi, et al.
Published: (2018-05-01)

The immunogenicity and safety of a Hib-MenAC vaccine: a non-inferiority randomized, observer-blind trial in infants aged 3-5 months
by: Yu-Xiao Wang, et al.
Published: (2017-05-01)

Diphtheria immunogenicity following the administration of pentavalent DTwP-HB-Hib vaccine at 4- and 8-week intervals: A randomized controlled trial
by: Ariesti Karmila, et al.
Published: (2025-09-01)

Adverse Events Following <i>Haemophilus influenzae</i> Type b (Hib) Monovalent Vaccines in Zhejiang Province, China, from 2017 to 2023
by: Xuejiao Pan, et al.
Published: (2025-03-01)

Monitoring of adverse reaction of Haemophilus influenzae type b vaccine in Songjiang District， Shanghai
by: SHEN Jinhua, et al.
Published: (2022-11-01)

SAFETY AND IMMUNOGENICITY OF A NATIONAL COMBINED VACCINE AGAINST PERTUSSIS, DIPHTHERIA, TETANUS, HEPATITIS B AND Hib-INFECTION, CONTAINING ACELLULAR PERTUSSIS COMPONENT, DURING IMMUNIZATION OF ADULTS
by: I. V. Feldblyum, et al.
Published: (2016-02-01)

Analysis of the dose-sparing effect of adjuvanted Sabin-inactivated poliovirus vaccine (sIPV)
by: Zhuofan Li, et al.
Published: (2018-08-01)

Surveillance for adverse events following immunization with DTaP-containing combination vaccines in Linping, China, 2019–2022
by: Qinghua Chen, et al.
Published: (2024-03-01)

Long Term Impact of Conjugate Vaccines on <i>Haemophilus influenzae</i> Meningitis: Narrative Review
by: Mary Paulina Elizabeth Slack
Published: (2021-04-01)

Sustained Immune Persistence Five Years Post-Completion of Four-Dose sIPV Vaccination
by: Chu Kai, et al.
Published: (2025-02-01)